TAUOPATHIES
and contain the hyperphosphorylated microtubuleassociated protein tau [1] . In this review, the molecular bases of AD, postencephalitic parkinsonism, ALS/PDC, PSP, CBD, Pick's disease, FTD, Down's syndrome, DM and NPC disease, all considered to be common tauopathies, will be discussed [1].
Alzheimer's Disease (AD). Alzheimer's disease is a progressive neurodegenerative disorder that leads to dementia and affects approximately 10% of the world population older than 65 years of age. Memory loss is followed by aphasia, agnosia, apraxia and behavioral disturbances [1] . Senile plaques and NFT are the main brain lesions observed in AD. The former result from extracellular accumulation of the peptide Aβ, derived from the β-amyloid precursor protein (APP), into amyloid deposits, which are diffusely and variably distributed throughout the cerebral cortex and in subcortical structures [2, 3] . In familial AD, mutations have been found on the APP gene [2] . The NFT consist of abnormal fibrils aggregated into paired helical filaments (PHF) and contain the hyperphosphorylated form of tau protein. They are usually observed in the large pyramidal cells of the hippocampus and entorhinal cortex, the supragranular and infragranular layers of the association cortical areas, nucleus basalis of Meynert, amygdala, locus coeruleus and dorsal raphe, the primary motor and sensory cortices being relatively spared. The demonstration of both senile plaques and NFT within these regions of the cerebral cortex is essential for a definite diagnosis of AD. However, NFT at a lower density are also present in the entorhinal cortex and hippocampus of normal elderly brains, whereas the neocortex exhibits only isolated NFT [1, 3] .
Postencephalitic Parkinsonism. Many patients who survived the influenza pandemic of [1916] [1917] [1918] [1919] [1920] [1921] [1922] [1923] [1924] [1925] [1926] later developed postencephalitic parkinsonism with extrapyramidal symptoms as the major clinical features. Affected patients did not show any cognitive changes and were usually neither aphasic nor apraxic [1] . Immunohistochemical analysis demonstrated that NFT were present in variable density in the hippocampus and entorhinal cortex, in neocortical areas and in subcortical regions. Higher NFT densities were observed in the hippocampus (CA1 and subiculum), area 20 of the neocortex and putamen, indicating that some regions were preferentially affected by the degenerative process [1, 4] .
Amyotrophic Lateral Sclerosis/Parkinsonism Dementia Complex (ALS/PDC) of Guam.
This chronic neurodegenerative disorder is highly prevalent in the native Chamorro population of Guam in the Western Pacific [2] . Clinically, it is indistinguishable from sporadic ALS and presents with fasciculations and signs of involvement of lower and upper motor neurons. Parkinsonism-dementia is characterized by an insidious progressive mental decline and extrapyramidal signs including bradykinesia, rigidity and, less often, tremors. Both aspects of the disease are frequently associated but may occur separately. The brain shows severe cortical atrophy and neuronal loss. There is widespread NFT formation, especially in the temporal and frontal isocortex, hippocampal formation and several sub cortical structures [2, 5] . Immunohistochemical studies have revealed that pathological tau proteins are present in the NFT [1] .
Progressive Supranuclear Palsy (PSP). This late-onset atypical parkinsonian disorder is characterized by supranuclear vertical gaze paralysis, moderate or severe postural instability with episodes of falling during the first year of onset of symptoms, and facial, nuchal and tron cular dystonia; dementia is common in the later stages [1, 5, 6] . Progressive supranuclear palsy is characterized by neuronal loss, gliosis and NFT formation. Subcortical localization of NFT in basal ganglia, brainstem and cerebellum, led to PSP being considered as a model of "subcortical dementias." However, degenerative lesions have been described in the perirhinal, inferior temporal and prefrontal cortex, the density of NFT varying among cases [6, 7] . Further studies have demonstrated that the primary motor cortex is more severely affected than the neocortical association areas when compared to AD [1, 5, 8] . Glial fibrillary tangles have been detected in PSP brains [5, [8] [9] [10] [11] .
Corticobasal Degeneration (CBD). This rare, sporadic and slowly progressive neurodegenerative disorder is clinically characterized by cognitive disturbances, e.g., aphasia and apraxia, and extrapyramidal motor dysfunction, e.g., rigidity, limb dystonia, akinesia and action trem or [1, 5] . Sometimes moderate dementia emerges late in the course of the disease. There is clinical and pathological overlap between PSP and CBD, so that distinction of these conditions on a neuropathological basis becomes very important. Neuropathological examination shows fronto parietal atrophy of the brain and glial and neuronal abnormalities [5, 11] . The glial pathology is dominated by astro cytic plaques, and numerous tau-immunoreactive inclusions in the white matter. The presence of achromatic ballooned neurons has been shown in cortex, brainstem and subcortical structures, as well as neuritic changes and NFT. Immunochemical studies have been given great importance in distinction of PSP and CBD [1, 5, 11] .
Pick's Disease. This rare disorder is characterized by a distinctly progressive dementia. Early in the clinical course, there are signs of frontal disinhibition including mood disturbances and progressive language impoverishment leading to mutism [1] . Prominent frontotemporal lobar atrophy, gliosis, severe neuronal loss, ballooned neurons and the presence of neuronal inclusions, called Pick bodies, in both cortical and subcortical structures are characteristic of the disease [1, 2] . Pick bodies contain tau protein and occur at higher density in the hippocampus than in the neocortex. In the former, Pick bodies are numerous in the granule cells of the dentate gyrus, in the CA1 field, the subiculum and the entorhinal cortex. In the latter, they are mainly found in layers II and VI of the anterior segment of temporal and frontal lobes [1, 2, 5] .
Frontotemporal Dementia (FTD). Historically, this has often been classified as a form of Pick's disease, even when Pick bodies were not present. However, FTD may be categorized with different subgroups. A consensus on clinical and neuropathological criteria for FTD has been published which clarified the distinction between Pick's disease and FTD [12] . An autosomal dominant disease related to FTD, characterized by adult-onset behavioral disturbances, frontal lobe dementia, parkinsonism and amyotrophy and linked to chromosome 17q21 has been described and is called FTD with parkinsonism linked to chromosome 17 (FTDP-17) [12] . Although clinical heterogeneity has been described between and within families with FTDP-17, the usual symptoms include behavioral changes, loss of frontal executive functions, language deficit and hyperorality [12, 13] . Parkinsonism and amyo trophy have been found in a few families, but are not consistent features [14] . Brains of FTD patients show atrophy of frontal and temporal lobes, severe neuronal cell loss, grey and white matter gliosis, and superficial laminar spongiosis. An important characteristic is the filamentous pathology that affects neuronal cells and/or glial cells in some cases. Tau mutations segregate with the pathology of FTDP-17 indicating their pathogenic role [13] [14] [15] .
Myotonic Dystrophy [DM]. This autosomal dominant and slowly progressive multisystemic disorder is characterized by myotonia, muscular atrophy, cataract and endocrine dysfunction. Affected individuals present with a highly variable phenotype, ranging from an asymptomatic condition to a severe congenital form. Impairment of intellectual and cognitive function in DM has been reported [16] . The molecular basis is an unstable CTG trinucleotide repeat in the 3' untranslated region (3'UTR) of a gene that encodes a putative Ser/Thr protein kinase (DM protein kinase), located on chromosome 19 [16] . There is reduced brain weight and minor abnormalities in gyral architecture, and a disordered cellular arrangement with neurons being present in subcortical white matter, and intracytoplasmic inclusion bodies in cortical and subcortical structures. The presence of abnormally frequent NFT has been reported in the temporal lobe, especially in the parahippocampal gyrus [16] . Immunoblotting has revealed taupositive inclusion bodies in the hippocampus, the entorhinal cortex and in most of the temporal areas. The amounts of tau proteins are higher in the most severely affected brains, but lower than in AD [1].
Down's Syndrome. Down's syndrome patients have numerous somatic dysfunctions that occur during development which are due to trisomy of chromosome 21. In particular, a deficit of growth and maturation of the brain is consistently described, and patients develop a variable degree of cognitive impairment, usually leading to dementia after 50 years of age [17] . Neuropathologically, severe neuronal loss has been described in the hippocampal formation, neocortex and in subcortical areas [17] . The formation of NFT and amyloid deposits occurs prior to neuro nal loss. Neurofibrillary degeneration with tau accumulation appears later in life. The hippocampal formation, including the entorhinal cortex, contains the highest number of NFT. Down's syndrome brain extracts contain significant amounts of insoluble tau [1, 17] .
Niemann-Pick Type C (NPC) Disease. This is a cholesterol storage disease with defects of intracellular trafficking of exogenous cholesterol derived from low density lipoproteins. Niemann-Pick type C includes juvenile dystonic lipidosis, ophthalmoplegic lipidosis, neuro visceral storage disease protein 1)-binding sites that are important in directing transcription initiation in other TATA-less promoters are present in the proximity of the first transcription initiation site. The SP1-binding sites have been suggested to control neuronal specific expression of tau [12, [21] [22] [23] [24] .
Three exons [4A, 6 and 8] are missing in the tau primary transcript expressed in the human brain and are specific to peripheral tau proteins. Exon 4A occurs in bovine, human and rodent peripheral tissues with a high degree of homology [22] . Exon -1 (minus one) is part of the promoter and is transcribed but not translated. Exons 1, 4, 5, 7, 9, 11, 12 and 13 are constitutive exons. Exon 14 is part of the 3'UTR of tau mRNA. Exons 2, 3 and 10 are alternatively spliced and are adult brain-specific [21] . Exon 3 never appears independently of exon 2. Thus, alternative splicing of these three exons allows for six combinations (2-3-10-; 2+3-10-; 2+3+10-; 2-3-10+; 2+3-10+; 2+3+10+) so that in the human brain, the tau primary transcript gives rise to six mRNAs ( Fig.  1) [21, 22, 25] .
The human brain tau isoforms contain from 352 to 441 amino acids (molecular mass from 45 to 65 kDa). They differ by the presence of either three (3R) with vertical supranuclear ophthal moplegia, and juvenile NPC disease [18] . The onset may be in infancy, early childhood, adolescence, or occasionally, in adulthood. Common neurological manifestations are clumsiness, ataxia, supranuclear gaze paresis, seizures and psychomotor retardation [19] . Brains from NPC patients exhibit neuronal distension in the cortex and swollen axons in the brainstem. In cases with a chronic progressive course, tau containing NFT are present in many parts of the brain, including the hippocampus, neocortex and several subcortical structures [20] . 
THE TAU GENE AND PROTEIN
The human tau gene extends over 100 kb on chromosome 17q21 and contains 16 exons. Restriction analysis and gene sequencing showed that it contains one CpG island associated with the promoter region, and another associated with exon 9. The CpG island in the former region resembles those described in neuron-specific promoters [21] [22] [23] [24] . The sequence of this region is TATA-less which indicates that it is likely to contain multiple initiation sites, as is typical of housekeeping genes [22] . Three SP1 (specificity
BALKAN JOURNAL OF MEDICAL GENETICS
Ozansoy M, Baþak AN or four (4R) repeat regions in the carboxy-terminal end and the absence or presence of one or two inserts (29 or 58 amino acids, respectively) in the aminoterminal end [12] . Since the isoforms are differentially expressed during development, each is likely to have a particular physiological role [12, 21] . Only one, characterized by 3R and no amino-terminal inserts, is present during fetal stages, but all six isoforms are expressed during adulthood. Their specific functions may be related to the absence or presence of regions encoded by exons 2, 3 and 10 [21, 26] , and the isoforms may not be equally expressed in neurons. For instance, tau mRNAs containing exon 10 are not found in granular cells of the dentate gyrus. Thus, tau isoforms may be differentially distributed in neuronal subpopulations [12, 21, 26, 27] . The presence or absence of 29 amino acid sequences encoded by exons 2 and 3 determine the length of the amino-terminal part of tau proteins [21] . These inserts are highly acidic and are followed by a basic proline-rich region (Fig. 2) . The amino-terminal Tau proteins bind to spectrin and actin filaments. Through these interactions, they may allow microtubules to interconnect with other cytoskeletal components, such as neurofilaments. There is evidence that tau also interacts with cytoplasmic organelles and the plasma membrane [29, 30, 31] .
Tau proteins bind to microtubules through the repeat domains (R1, R2, R3 and R4) encoded by exons 9-12 in their carboxy-terminal region. The 3R or 4R copies of a highly conserved 18-amino acid repeat are separated from each other by less conserved 13-or 14-amino acid inter-repeat domains. Tau proteins act as promoters of tubulin polymerization in vitro, and are involved in axonal transport [29] . The 18-amino acid repeats bind to microtubules through a variety of weak interactions. Adult tau isoforms with 4R are more efficient at promoting microtubule assembly than the fetal isoform with 3R [21, 29] . The most potent in inducing microtubule polymerization is the inter-region between R1 and R2 which is unique to 4R-tau. Recent evidence supports a role for the microtubule-binding domain in the modulation of the phosphorylation state of tau proteins [21, 30] .
Posttranslational Modifications in Tau Proteins. One posttranslational modification observed in the tau protein is O-glycosylation [32] . The number of O-GlcN Acylated sites on tau protein is lower than the number of phosphorylation sites. Although the functional significance of O-GlcNAc modification is not fully understood, it is implicated in transcriptional regulation, protein degradation, cell activation, region is referred to as the projection domain, since it projects from the microtu bule surface where it may interact with other cytoskeletal elements and with the plasma membrane [28] . In fact, projection domains of tau determine spacings between microtubules in an axon and may increase axonal diameter. In peripheral neurons, which often project a very long axon with a large diameter, an additional amino-terminal sequence encoded by exon 4A is present, producing the specific isoform called "big tau" [21, 27, 28] .
CLASSIFICATION OF TAU AGGREGATION IN TAUOPATHIES
Class 0: No Tau Aggregates. After AD, frontal lobe degeneration is the second most common pre senile dementia disorder in Europe [21] . It has a frontal pathology, like Pick's disease, but no specific neuropathological hallmark. Morphological changes comprise neuronal cell loss, spongiosis and gliosis, mainly in the superficial cortical layers of the frontal and temporal cortex. No tau aggregates are observed although loss of tau protein expression is demonstrated in this disorder, also named DLDH (dementia lacking distinctive histopathological) [21] .
Class 1: A Major Tau Triplet of 60, 64, 69 kDa. This class is characterized by a pathological tau triplet of isoform of 60, 64, and 69 kDa and a minor pathological tau of 72/74 kDa. This tau isoform triplet arises from aggregation among the six tau isoforms [1, 12, 21] . Thus, tau 60 is composed of the shortest tau isoform, and tau 64 and 69 are mixtures of tau isoforms with exon 10 or exon 2 alone, and exon2+10+ or exon2+3+, respectively. The longest tau isoform including exon 2+3+10+ constitutes the 72/74 kDa component. The prototypical neurode generative disorder that characterizes this class is AD, but this class also includes FTDP-17, ALS/PDC of Guam, postencephalitic parkinsonism, Down's syndrome and NPC [1, 21] .
Class 2: A Major Tau Doublet of 64 and 69 kDa. This class is characterized by aggregation of 4R-tau iso form and is observed in PSP, CBD and FTDP-17. In both PSP and CBD, the pathological tau profile consists of the aggregation of 4R-tau isoforms, although a study of a large series of PSP In tauopathies other than AD, abnormally and hyper phosphorylated tau protein aggregates are observed in the absence of amyloid deposits. Since tau aggregates differ in both degree of phosphorylation and content of tau iso forms, a molecular classification (depending on the molecular masses of the tau aggregates) into five classes has been proposed for the tauopathies (Fig. 3) [13, 21] .
cell cycle regulation and the proper assembly of multimeric protein complexes [32, 33] . O-GlcNAcylation may have a role in mediating interaction of tau with tubulin or in subcellular localization and degradation of tau [32, [33] [34] [35] .
Another posttranslational modification seen in tau is phosphorylation. There are 80 putative serine or threonine phosphorylation sites in the longest (441 amino acid) brain tau isoform [21] . Microtubule assembly depends partially upon the phosphorylation state, since phosphorylated tau is less effective than non phosphorylated tau in microtu bule polymerization. In many neurodegenerative disorders, tau proteins aggregate into intracellular filamentous inclusions [36] . In AD, these inclusions are PHF, their constituent proteins are referred to as PHF-tau, and are found in a hyperphosphorylated state. There is a direct relationship between hyperphosphorylation, abnormal phosphorylation and tau aggregation, but it remains to be determined whether phosphorylation is a cause or a consequence of the aggregation process [36] [37] [38] . 
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Mutation

TAU MUTATIONS/POLYMORPHISMS AND TAUOPATHIES
patients revealed that the pathological tau profile is heterogeneous and includes variable amounts of 3R-tau isoforms [21] . Thus, an increased ratio of 4R/3R tau isoform is considered to define this class of tauopathies [11, 13, 21] . Class 3: A Major Tau Doublet of 60 and 64 kDa. In all cases of Pick's disease, the disorder characteristic of class 3, a major 60 and 64 kDa tau doublet is observed. The tau profile of Pick's disease is the opposite of that of class 2. The pathological isoforms consist of the 3R-tau isoforms [21] .
Class 4: A Major Tau of 60 kDa. This class consists only of DM type 1 (DM1). The tau profile of DM1 is characterized by a strong tau band of 60 kDa and to a lesser extent, of isoforms of 64 and 69 kDa [21] . This profile reflects a reduced number of isoforms expressed in the brain of DM1 patients, at both the protein and the mRNA levels. Using specific immunological probes against amino acid sequences in exon 2 and exon 3, the neurofibrillary lesions were shown to be devoid of tau isoforms with amino-terminal inserts [1, 21] . An altered splicing of tau gene transcript is considered to be the cause, although the mechanism remains to be established. This demonstrates that the central nervous system is affected in DM1, making this a real tauopathy [21] .
As of 2004, 34 pathogenic tau mutations have been described in 101 FTDP-17 families [25]. They include 21 missense mutations, three silent mutations, two in-frame single codon deletions, and nine intronic mutations (Table 1 ). In addition, 17 coding polymorphisms have been reported [25] . The mutations are clustered in exons 9-13 which encode the microtubule-binding domain and flanking regions [39, 40] . Most coding polymorphisms are with in exons 4A, 6 and 8, that are not expressed in any of the major brain isoforms [39, 41, 42] . The most frequently observed mutations are a C→T substitution corresponding to P301L* in exon 10 (identified in 25 families) and IVS-10+16 (C→T) in intron 10 (identified in 22 families). In contrast, 21 mutations were reported in a single family [25] . Almost all mutations are heterozygous and segregate in a dominant manner within families; however, homozygous N296del* and S352L* mutations have been observed in siblings of consanguineous marriages [25, 43, 44] .
Mutations in tau proteins may affect alternative splicing of exon 10 and lead to changes in the proportion of 4R-and 3R-tau isoforms, or modify tau TAUOPATHIES interactions with microtubules [21, 25] . The former group includes intronic mutations (+3, +13, +14, +16) and some missense mutations. Intronic mutations destabilize a stem loop structure in the 5' splice site of exon 10 that stabilizes this region of the premRNA [45] [46] [47] . Without this stem loop, access of U1snRNP to this site may be facilitated, increasing the formation of exon 10+ tau mRNAs, and thus, the 4R-tau isoform [21] . In FTDP-17 families that carry these mutations, abnormally phosphorylated 4R-tau isoforms aggregate into filaments and display an electrophoretic profile similar to the major tau doublet of 64 and 69 kDa seen in PSP and CBD [21] . Some missense mutations also modify the splicing of exon 10 (Fig. 4) . The change in nucleotide that results in N279K* and S305N* mutations also creates an exon-splicing enhancer sequence. The silent mutation L284L* increases the formation of tau mRNAs containing exon 10, presumably by destroying an exon-splicing silencing element. Families with one of these three missense mutations show the same tau electrophoretic profile as those having intronic mutations [25, 45] . The latter group of tau mutations consists of missense mutations that affect microtubule assembly and polymerization. When located in the tau regions outside exon 10 they affect all tau iso forms so that none can properly bind to microtubules. These proteins aggregate into PHF and straight filaments in neuronal cells. Conversely, when these mutations are located in exon 10, 4R-tau isoforms are affected which do not bind to microtubules and aggregate into twisted ribbon filaments. This type of filamentous inclusion has been described in both neuronal and glial cells [21, 48, 49] .
Mutations of the tau gene and their involvement in FTDP-17 emphasize the fact that abnormal tau proteins may play a central role in the pathogenesis of neuro degenerative disorders, without involvement of the amyloid cascade [1, 21] . The functional effects of the mutations suggest that a reduced ability of tau to interact with micro tubules may be the first event upstream of hyperphos phorylation and aggregation. These mutations may also lead to an increase in free cytoplasmic tau (especially 4R-tau isoforms which facilitates their aggregation into filaments [50, 51] .
Even before tau mutations were identified in FTDP-17 families, over representation of the most frequent allele (A0) of a dinucleotide repeat polymorphism, located in intron 9 of tau in PSP patients, had been reported [52] . This association has been confirmed in four independent populations [53] [54] [55] [56] . Sequencing of the tau gene in FTDP-17 patients 
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Ozansoy M, Baþak AN identified a series of polymorphisms within intronic sequences flanking tau exons [25, 54] . Analysis of these polymorphisms revealed them to be in complete linkage disequilibrium with the intron 9 microsatellite, and led to identification of two major tau haplotypes (H1 and H2) extending over the complete coding tau region and the 5' promoter region of exon -1 (minus one) [7, 25, [57] [58] [59] . Recombination events between H1 and H2 have not been observed. Because the A0 allele is inherited as part of H1, increased frequencies of H1 in PSP populations have been identified [52, 53] . Moreover, association studies in two CBD populations demonstrated similarly increased H1 frequencies, supporting a common genetic susceptibility for PSP and CBD [60, 61] . Genetic investigation of the saitohin gene (STH) located within tau intron 9, revealed a coding polymorphism changing a glutamine (Q) to an arginine (R) at codon 7. Since the Q allele of STH is part of H1, it is no surprise that the positive association of PSP with tau is replicated by genotyping the Q7R polymorphism [62, 63] . In most populations, genotypic (H1H1) association is more significant than allelic (H1) association, suggesting the existence of a recessive mutation or a dosage-sensitive risk allele on H1 [25] . Both PSP and CBD are characterized by parkinsonism and neurodegeneration. Although they are pathologically distinct, similar tau deposits, predominantly composed of 4R-tau isoforms, are found in the brains of these patients. It remains unclear how the presence of H1 would result in 4R-tau pathology. Although H1 and H2 differ within tau coding regions, missense mutations have only been identified in exons 4A and 6, which are not expressed in the major human brain isoforms. Since H1 is present in approximately 80% of the Cauca sian population, extensive sequencing analysis of the H1 carriers is necessary to identify genetic variations that define disease-specific H1 subhaplotypes [25] .
Tau association studies in other tauopathies (FTD, Pick's disease and AD) were negative or inconsistent in independent studies [1, 25] . Although H1H1 frequencies were found to be moderately increased in all FTD populations, they did not reach statistical significance [25] . The majority of tau association studies in AD populations were negative. Two studies, containing neuropathologically diagnosed Pick's disease patients, gave slightly increased association with the H2H2 genotype [64, 65] .
CONCLUSIONS
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Aggregation of tau proteins in filamentous inclusions is a common feature of several neurodegenerative disorders. The laminar and regional distributions of NFT or other inclusions differ among conditions associated with dementia. The electrophoretic profiles of pathological tau proteins permit classification of these diseases on a basis of their biochemical signatures. These profiles may be explained by selective aggregation of specific sets of tau isoforms, differential vulnerability of neuronal subpopu lations, and possibly variable sets of enzymes (kinases and/or phosphatases) that affect the phosphorylation state of the tau isoforms [1, 21, 25] .
Mapping of the spatiotemporal distribution of tau pathology in different brain areas is important in understanding how the disease spreads in the brain. While tau gene mutations simultaneously affect different brain areas, many sporadic tauopathies affect first a specific vulnerable area, e.g., the entorhinal cortex and hippocampal area in AD, the brainstem in PSP and CBD. The extension of tauopathy in AD correlates with the evolution of cognitive deficits, from memory disorders to language impairment and then to apraxia and agnosia. It is interesting that the tau pathologies in PSP and CBD are quite different from those seen in AD, since they emerge from subcortical nuclei toward the neocortex, especially toward frontal motor cortex [25] . Overall, the results discussed here, indicate that the key event in the tauopathies is disorganization of the cytoskeleton that leads to nerve cell degeneration, whether the primary cause is a tau gene mutation and/or polymorphism or some other unidentified factors.
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